[Passage into the human milk and clinical evaluation of sulbactam/cefoperazone]

Jpn J Antibiot. 1985 Feb;38(2):223-9.
[Article in Japanese]

Abstract

A combined agent of sulbactam, a beta-lactamase inhibitor, plus cefoperazone (SBT/CPZ: 1/1) was studied on the passage into the maternal milk as well on the clinical application and the results were followings: One or 2 grams of SBT/CPZ was given by one shot intravenous injection to puerperal mothers to determine the passage into the milk up to 6 hours after the administration. A trace of passage was detected for both SBT and CPZ as in the case of other antibiotics. Good clinical efficacy was observed in all 5 patients with female genital organ infections, to whom a daily dose of 2.0 g of SBT/CPZ was administered by drip infusion for 4 to 6 days. No side effects were noticed.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Bacterial Infections / drug therapy*
  • Cefoperazone / administration & dosage*
  • Cefoperazone / metabolism
  • Cefoperazone / therapeutic use
  • Drug Combinations
  • Drug Evaluation
  • Female
  • Genital Diseases, Female / drug therapy*
  • Humans
  • Infusions, Parenteral
  • Injections, Intravenous
  • Milk, Human / metabolism*
  • Penicillanic Acid / administration & dosage*
  • Penicillanic Acid / metabolism
  • Penicillanic Acid / therapeutic use
  • Pregnancy
  • Sulbactam
  • beta-Lactamase Inhibitors

Substances

  • Drug Combinations
  • beta-Lactamase Inhibitors
  • Cefoperazone
  • Penicillanic Acid
  • Sulbactam